Barely Significant
← all excerpts

Analysis of FNDC1 as a diagnostic marker and potential therapeutic target for ovarian serous cancer.

BMC Cancer · 2025 · PMC12532397 · PMID 41102682

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Of them, the results revealed that FNDC1 exhibited highly significant differential expression ( p < 0.001) in 20 TCGA cancer types, including OV, breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma (STAD), etc.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.